Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Bullboard Posts
Post by ready2go1on Jun 22, 2010 3:25pm
310 Views
Post# 17211717

GPRO's Europe call

GPRO's Europe callGen-Probe was in Europe today for an investor presentation. A couple quick points, for one thing, you can hear these guys speak every day about their business plan and they are very conservative in their outlook but at times they will change up their wording  on a specific market that will shed some light on their plans.
     They said that PCA3 is growning at 50% year over year and they expect about $10 million in revenue this year. They are on tract with Panther and said that once PCA3 is up and running on Panther, they feel they have a "Blockbuster"
      Again, I am not sure what will grab investors attention; GPRO submitting to the FDA, ramp up in sales #'s, or FDA approval.
Bullboard Posts